Rainbow Children’s Medicare IPO (Initial Public Offering) is opening for subscription on April 27, 2022 and will be open for bidding until April 29, 2022. healthcare company plan 1595.59 crore from this public offering. However, early signs of a gray market could demoralize the company and potential investors. According to market observers, the Rainbow Children’s Medicare IPO Gray Market Premium (GMP) has been declining since its launch in the gray market. He said shares of Rainbow Children’s Medicare are currently trading at a premium to 35 in the gray market.
Rainbow Children Medicare IPO GMP
According to Market Observers, Rainbow Children’s Medicare IPO is GMP Today 35, which is 3 less than yesterday’s gray market premium. He added that the Rainbow Children’s Medicare IPO gray market premium has been falling steadily since it debuted in the gray market. He Said The Rainbow Children’s Medicare IPO Made Its Debut 52 on friday but on saturday it came down 38 and today it’s on 35. Observers further said that such a fall in the gray market premium of the public issue can be attributed to weak sentiments in the secondary markets. A correction can be expected after the trend reversal on Dalal Street.
What does this GMP mean?
As Market Observers Reported, Rainbow Children’s Medicare IPO GMP Is Today 35, which means the gray market is expecting this IPO to list around 577 ( 542 + 35), which is about 60.50 per cent higher than its upper price band.
Speaking on the Fundamentals of Rainbow Children Medicare; Abhay Doshi, Founder, UnlistedArena.com, said, “Rainbow Children Medicare Limited is leading the multi-specialty hospital chain in India, primarily following a hub-and-spoke model in six cities with a total capacity of 1500 beds. working in On the operational front, the company has posted stable top and bottom line numbers, however, the 9MFY22’s performance appears to be exceptional. ,
“At the upper price band, Pre-Fresh Issue, the asking P/E comes to around 128x and Market Cap to Revenue comes to around 8x on FY2011 financial basis. The demand valuation is in line with the listed companies. However, it will be curious to see if the company can sustain the performance of 9MFY21 going forward,” Doshi said.
Disclaimer: The views and recommendations given above are those of individual analysts or broking companies and not of Mint.